|
1
|
Zhu W, Zou B and Wang S:
Clinicopathological features and prognosis of sinonasal mucosal
malignant melanoma: A retrospective study of 83 cases in a Chinese
population. ORL J Otorhinolaryngol Relat Spec. 78:94–104. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Safadi RA, Bader DH, Abdullah NI and
Sughayer MA: Immunohistochemical expression of keratins 6, 7, 8,
14, 16, 18, 19, and MNF-116 pancytokeratin in primary and
metastatic melanoma of the head and neck. Oral Surg Oral Med Oral
Pathol Oral Radiol. 121:510–519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bradley PJ: Primary malignant mucosal
melanoma of the head and neck. Curr Opin Otolaryngol Head Neck
Surg. 14:100–104. 2006.PubMed/NCBI
|
|
4
|
Smith SM, Schmitt AC, Carrau RL and
Iwenofu OH: Primary sinonasal mucosal melanoma with aberrant
diffuse and strong desmin reactivity: A potential diagnostic
pitfall! Head Neck Pathol. 9:165–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thomas NE, Kricker A, Waxweiler WT, Dillon
PM, Busman KJ, From L, Groben PA, Armstrong BK, Anton-Culver H,
Gruber SB, et al: Comparison of clinicopathologic features and
survival of histopathologically amelanotic and pigmented melanomas:
A population-based study. JAMA Dermatol. 150:1306–1314. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Agaimy A, Specht K, Stoehr R, Lorey T,
Märkl B, Niedobitek G, Straub M, Hager T, Reis AC, Schilling B, et
al: Metastatic malignant melanoma with complete loss of
differentiation markers (undifferentiated/dedifferentiated
melanoma): Analysis of 14 patients emphasizing phenotypic
plasticity and the value of molecular testing as surrogate
diagnostic marker. Am J Surg Pathol. 40:181–191. 2016.PubMed/NCBI
|
|
7
|
Liu J, Wang Y and Liu Y, Liu Z, Cui Q, Ji
N, Sun S, Wang B, Wang Y, Sun X and Liu Y: Immunohistochemical
profile and prognostic significance in primary central nervous
system lymphoma: Analysis of 89 cases. Oncol Lett. 14:5505–5512.
2017.PubMed/NCBI
|
|
8
|
Montone KT: The diferential diagnosis of
sinonasal/nasopharynheal neuroendocrine/neuroectodermally derived
tumors. Arch Pathol Lab Med. 139:1498–1507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Houette A, Gilain L, Mulliez A, Mom T and
Saroul N: Prognostic value of two tumour staging classifications in
patients with sinonasal mucosal melanoma. Eur Ann Otorhinolaryngol
Head Neck Dis. 133:313–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thompson LD, Wieneke JA and Miettinen M:
Sinonasal tract and nasopharyngeal melanomas: A clinicopathologic
study of 115 cases with a proposed staging system. Am J Surg
Pathol. 27:594–611. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Teixeira TF, Gentile LB, da Silva TC,
Mennecier G, Chaible LM, Cogliati B, Roman MA, Gioso MA and Dagli
ML: Cell proliferation and expression of connexins differ in
melanotic and amelanotic canine oral melanomas. Vet Res Commun.
38:29–38. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kerr EH, Hameed O, Lewis JS Jr, Bartolucci
AA, Wang D and Said-AI-Naief N: Head and neck mucosal malignant
melanoma: Clinicopathologic correlation with contemporary review of
prognostic indicators. Int J Surg Pathol. 20:37–46. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jalas JR, Vemula S, Bezrookove V, Leboit
PE, Simko JP and Bastian BC: Metastatic melanoma with striking
adenocarcinomatous differentiation illustrating phenotypic
plasticity in melanoma. Am J Surg Pathol. 35:1413–1418. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Franchi A: An update on sinonasal round
cell undifferentiated tumors. Head Neck Pathol. 10:75–84. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh L, Ranjan R, Arava S and Singh MK:
Role of p40 and cytokeratin 5/6 in the differential diagnosis of
sinonasal undifferentiated carcinoma. Ann Diag Pathol. 18:261–265.
2014. View Article : Google Scholar
|
|
16
|
Folpe AL, Chand EM, Goldblum JR and Weiss
SW: Expression of Fli-1, a nuclear transcription factor,
distinguishes vascular neoplasms from potential mimics. Am J Surg
Pathol. 25:1061–1066. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Torlakovic EE, Slipicevic A, Flørenes VA,
Chibbar R, DeCoteau JF and Bilalovic N: Fli-1 expression in
malignant melanoma. Histol Histopathol. 23:1309–1314.
2008.PubMed/NCBI
|
|
18
|
Ordóñez NG and Mackay B: Electron
microscopy in tumor diagnosis: Indications for its use in the
immunohistochemical era. Hum Pathol. 29:1403–1411. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Ding N, Li Y, Cheng H, Wang D,
Yang Q, Deng Y, Yang Y, Li Y, Ruan X, et al: Insulin-like growth
factor binding protein 5 (IGFBP5) functions as a tumor suppressor
in human melanoma cells. Oncotarget. 6:20636–20649. 2015.PubMed/NCBI
|
|
20
|
Zimmerer RM, Korn P, Demougin P, Kampmann
A, Kokemüller H, Eckardt AM, Gellrich NC and Tavassol F: Functional
features of cancer stem cells in melanoma cell lines. Cancer Cell
Int. 13:782013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuk SK, Won CH, Lee WJ, Shin WJ, Yoon HJ,
Hong SD, Hong SP and Lee J II: Prognostic significance of nestin in
primary malignant melanoma of the oral cavity. Melanoma Res.
26:457–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Klein D, Meissner N, Kleff V, Jastrow H,
Yamaguchi M, Ergün S and Jendrossek V: Nestin (+) tissue-resident
multipotent stem cells contribute to tumor progression by
differentiating into pericytes and smooth muscle cells resulting in
blood vessel remodeling. Front Oncol. 4:1692014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng L, Huang Z, Zhou W, Wu Q, Donnola S,
Liu JK, Fang X, Sloan AE, Mao Y, Lathia JD, et al: Glioblastoma
stem cells generate vascular pericytes to support vessel function
and tumor growth. Cell. 153:139–152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spiliopoulos K, Peschos D, Batistatou A,
Ntountas I, Agnantis N and Kitsos G: Vasculogenic mimicry: Lesson
from melanocytic tumors. In Vivo. 29:309–317. 2015.PubMed/NCBI
|
|
26
|
Wang SS, Gao XL, Liu X, Gao SY, Fan YL,
Jiang YP, Ma XR, Jiang J, Feng H, Chen QM, et al: CD133+ cancer
stem-like cells promote migration and invasion of salivary adenoid
cystic carcinoma by inducing vasculogenic mimicry formation.
Oncotarget. 7:29051–29062. 2016.PubMed/NCBI
|
|
27
|
Hendrix MJ, Seftor EA, Seftor RE, Chao JT,
Chien DS and Chu YW: Tumor cell vascular mimicry: Novel targeting
opportunity in melanoma. Pharmacol Ther. 159:83–92. 2016.
View Article : Google Scholar : PubMed/NCBI
|
